Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Loading Doses for Propofol Sedation in Upper GI Endoscopy
NCT06414395Phase 4Recruiting
- Sponsor
- Theodor Bilharz Research Institute
- Start
- May 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Procedural sedation (PS) (4 arms), sponsored by Theodor Bilharz Research Institute. Primary endpoint: Recovery time of each group at 0 days. Started May 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT06414395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06414395.